Distinct oncogenic signatures in malignant PEComa and leiomyosarcoma identified by integrative RNA-seq and H3K27ac ChIP-seq analysis.
Krinio Giannikou(University of California San Diego), David J. Kwiatkowski(Brigham and Women's Hospital), Michelle S. Hirsch(Perinatal Institute), Len Taing(Dana-Farber Cancer Institute), Nikolas Kesten(Dana-Farber Cancer Institute), Elio Adib(Dana-Farber Brigham Cancer Center), Andrew J. Wagner(Dana-Farber Cancer Institute), Ahmad-Abdel Azim(Brigham and Women's Hospital), Jason L. Hornick(Harvard University), Inga‐Marie Schaefer(Brigham and Women's Hospital), Henry W. Long(Dana-Farber Cancer Institute), Zachary Zhu(Brigham and Women's Hospital)
Cited by 2
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
Cistrome: an integrative platform for transcriptional regulation studies
|Genome biology|2011|792
Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
|JAMA Oncology|2018|689
Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse
|Nucleic Acids Research|2016|672
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656